Zepbound for Sleep Apnea: What Chicago Patients Should Know
If you’ve been diagnosed with obstructive sleep apnea and obesity, you may not have heard about a new treatment option that didn’t exist even a year ago. Zepbound (tirzepatide) recently became the first FDA-approved medication specifically for moderate-to-severe obstructive sleep apnea in adults with obesity. This approval represents a significant shift in how physicians can… Read More









